Imbruvica (ibrutinib) 140 mg capsules, 90 capsules — original (Janssen, Switzerland) Imbruvica. Targeted cancer therapy. Delivery from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.
Indications:
- Imbruvica is used to treat mantle cell lymphoma in adult patients who have relapsed or failed to respond to previous treatment.
- Imbruvica is used to treat chronic lymphocytic leukemia in adult patients who have received at least one prior therapy, or as first-line therapy in patients with a 17p deletion or TP53 mutation who are not eligible for chemoimmunotherapy.
- 4800kb
- Trade Name:Imbrovica
- Chemical Name:Ibrutinib
- Dosage:140 mg
- Quantity:90
- Form of Issue:Tablets
No reviews yet